Breaking Bottlenecks: Enhancing Autologous Cell Therapy Manufacturing
Part 9 of our Bridging the Gap Series (Summary of the webinar session held in August 2024) In the evolving landscape of cell and gene therapy, the manufacturing process is a crucial factor in ensuring that innovative treatments, such as CAR T-cell therapies, reach patients effectively. Autologous cell therapies, which involve modifying a patient’s own cells, present […]
View Blog





















